Related Experiment Video
Updated: Feb 15, 2026

Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
EYA2 promotes lung cancer cell proliferation by downregulating the expression of PTEN
Zhaoming Li1, Ran Qiu2, Xia Qiu3
1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
Lung cancer is the leading cause of cancer-related death worldwide. Despite advances have been made in diagnosis and therapeutic strategies, the prognosis of lung cancer is still very poor. Eyes absent transcriptional cofactor EYA2 has been shown to promote lung cancer cell growth, however, the underlying molecular mechanism is still not fully understood. In the present study, we found that EYA2 was up-regulated in lung cancer, and EYA2 led to increased cell proliferation by inhibiting Phosphatase and tensin homologue (PTEN) expression via modulation of miR-93. Additionally, survival analysis showed that lung cancer patients with higher EYA2 expression predicted a worse prognosis. Therefore, these findings demonstrate that EYA2 may play an important role in lung cancer occurrence and progression. Targeting EYA2 may provide a feasible approach in developing novel anticancer therapeutics.
Insights
Eyes absent transcriptional cofactor EYA2 promotes lung cancer growth by inhibiting PTEN expression through miR-93. Higher EYA2 levels in lung cancer patients correlate with a worse prognosis, suggesting EYA2 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Lung cancer remains a leading cause of cancer mortality globally.
- Current diagnostic and therapeutic strategies offer limited improvement in patient prognosis.
- The precise molecular mechanisms by which Eyes absent transcriptional cofactor EYA2 (EYA2) drives lung cancer progression are not fully elucidated.
Purpose of the Study:
- To investigate the role of EYA2 in lung cancer development and progression.
- To elucidate the molecular pathway through which EYA2 influences lung cancer cell proliferation.
- To assess the prognostic significance of EYA2 expression in lung cancer patients.
Main Methods:
- Quantitative analysis of EYA2 expression in lung cancer tissues.
- Investigation of EYA2's effect on cell proliferation.
- Exploration of the regulatory relationship between EYA2, miR-93, and Phosphatase and tensin homologue (PTEN).
- Survival analysis correlating EYA2 expression with patient outcomes.
Main Results:
- EYA2 expression is significantly upregulated in lung cancer tissues.
- Increased EYA2 expression promotes lung cancer cell proliferation.
- EYA2 inhibits PTEN expression by modulating miR-93 activity.
- Elevated EYA2 levels are associated with a poorer prognosis in lung cancer patients.
Conclusions:
- EYA2 plays a critical role in the occurrence and progression of lung cancer.
- The EYA2/miR-93/PTEN axis is a key pathway driving lung cancer cell proliferation.
- Targeting EYA2 presents a potential therapeutic strategy for lung cancer treatment.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Cell Specific Gene Expression

